Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...
Navigating a partner’s exit from a business can be challenging, but with careful planning and execution, it can lead to ...
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
The Fund, which is registered under the Investment Company Act of 1940 (the "'40 Act"), provides qualified investors exposure to venture capital, private equity and private credit investments through ...